Cargando…
Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19
This case-control study examines the association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with coronavirus disease 2019 (COVID-19).
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Medical Association
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426743/ https://www.ncbi.nlm.nih.gov/pubmed/32789513 http://dx.doi.org/10.1001/jamanetworkopen.2020.17708 |
| _version_ | 1783570745332334592 |
|---|---|
| author | van de Veerdonk, Frank L. Kouijzer, Ilse J. E. de Nooijer, Aline H. van der Hoeven, Hans G. Maas, Coen Netea, Mihai G. Brüggemann, Roger J. M. |
| author_facet | van de Veerdonk, Frank L. Kouijzer, Ilse J. E. de Nooijer, Aline H. van der Hoeven, Hans G. Maas, Coen Netea, Mihai G. Brüggemann, Roger J. M. |
| author_sort | van de Veerdonk, Frank L. |
| collection | PubMed |
| description | This case-control study examines the association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with coronavirus disease 2019 (COVID-19). |
| format | Online Article Text |
| id | pubmed-7426743 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Medical Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74267432020-08-19 Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19 van de Veerdonk, Frank L. Kouijzer, Ilse J. E. de Nooijer, Aline H. van der Hoeven, Hans G. Maas, Coen Netea, Mihai G. Brüggemann, Roger J. M. JAMA Netw Open Research Letter This case-control study examines the association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with coronavirus disease 2019 (COVID-19). American Medical Association 2020-08-13 /pmc/articles/PMC7426743/ /pubmed/32789513 http://dx.doi.org/10.1001/jamanetworkopen.2020.17708 Text en Copyright 2020 van de Veerdonk FL et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License. |
| spellingShingle | Research Letter van de Veerdonk, Frank L. Kouijzer, Ilse J. E. de Nooijer, Aline H. van der Hoeven, Hans G. Maas, Coen Netea, Mihai G. Brüggemann, Roger J. M. Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19 |
| title | Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19 |
| title_full | Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19 |
| title_fullStr | Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19 |
| title_full_unstemmed | Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19 |
| title_short | Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19 |
| title_sort | outcomes associated with use of a kinin b2 receptor antagonist among patients with covid-19 |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426743/ https://www.ncbi.nlm.nih.gov/pubmed/32789513 http://dx.doi.org/10.1001/jamanetworkopen.2020.17708 |
| work_keys_str_mv | AT vandeveerdonkfrankl outcomesassociatedwithuseofakininb2receptorantagonistamongpatientswithcovid19 AT kouijzerilseje outcomesassociatedwithuseofakininb2receptorantagonistamongpatientswithcovid19 AT denooijeralineh outcomesassociatedwithuseofakininb2receptorantagonistamongpatientswithcovid19 AT vanderhoevenhansg outcomesassociatedwithuseofakininb2receptorantagonistamongpatientswithcovid19 AT maascoen outcomesassociatedwithuseofakininb2receptorantagonistamongpatientswithcovid19 AT neteamihaig outcomesassociatedwithuseofakininb2receptorantagonistamongpatientswithcovid19 AT bruggemannrogerjm outcomesassociatedwithuseofakininb2receptorantagonistamongpatientswithcovid19 |